Position in BMY
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$4,227,060
-$546,337 QoQ
Shares Held
73,361
-6.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#154
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $22,172,877 across 17 Drug Manufacturers - General names. BMY ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,562 | $4,272,370 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
73,361 | $4,227,060 | |
| 3 | JNJ |
Johnson & Johnson
|
13,834 | $3,513,420 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | NVS |
Novartis AG
|
10,771 | $1,688,031 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,085 | $1,552,922 | |
| 7 | AZN |
Astrazeneca PLC
|
7,263 | $1,377,210 | |
| 8 | AMGN |
Amgen Inc
|
1,980 | $716,997 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,227,060 | 73,361 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $4,773,397 | 78,704 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $4,055,101 | 75,178 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $3,635,962 | 80,620 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,466,334 | 74,883 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $4,961,414 | 81,348 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $4,450,706 | 78,690 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $3,569,956 | 68,998 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,849,456 | 68,612 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $3,711,284 | 68,436 | Shares | Sole | 2024-04-03 | |
| 2023-12-31 | $3,558,553 | 69,354 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $4,032,503 | 69,478 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,441,519 | 69,453 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $4,811,916 | 69,426 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $4,929,150 | 68,508 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $4,904,356 | 68,988 | Shares | Sole | 2022-12-30 | |
| 2022-06-30 | $5,312,076 | 68,988 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,039,289 | 69,003 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $4,303,085 | 69,015 | Shares | Sole | 2022-01-06 | |
| 2021-09-30 | $4,083,972 | 69,021 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $5,551,472 | 83,081 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $5,245,219 | 83,086 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $5,153,824 | 83,086 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,009,435 | 83,089 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $4,884,986 | 83,078 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $4,631,269 | 83,087 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||